Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Clinical trial NCT01841736 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01841736
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Foregut Neuroendocrine Tumor Hindgut Neuroendocrine Tumor Metastatic Digestive System Neuroendocrine Tumor G1 Metastatic Neuroendocrine Tumor Midgut Neuroendocrine Tumor G1 Neuroendocrine Tumor G2 Recurrent Digestive System Neuroendocrine Tumor G1 Regional Digestive System Neuroendocrine Tumor G1

Start date: 2013-09-20
Primary completion: 2019-03-05
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.